A DDB2 mutant protein unable to interact with PCNA promotes cell cycle progression of human transformed embryonic kidney cells

References

• Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 2008; 22(18):2496-506; http://dx.doi.org/10.1101/gad.1676108
   PubMed Web of Science ®Google Scholar
• Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9(6):400-14; PMID:19440234; http://dx.doi.org/10.1038/nrc2657
   PubMed Web of Science ®Google Scholar
• Barakat BM, Wang QE, Han C, Milum K, Yin DT, Zhao Q, Wani G, Arafa e-S, El-Mahdy MA, Wani AA. Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis. Int J Cancer 2010; 127(4):977-988; PMID:20013802
   PubMed Web of Science ®Google Scholar
• Barckhausen C, Roos WP, Naumann SC, Kaina B. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair. Oncogene 2014; 33(15):1964-1974; PMID:23604128; http://dx.doi.org/10.1038/onc.2013.141
   PubMed Web of Science ®Google Scholar
• Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6:620-6; PMID:4064842; http://dx.doi.org/10.1002/cyto.990060618
   PubMedGoogle Scholar
• Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 2010; 704(1-3):12-20; PMID:20096807; http://dx.doi.org/10.1016/j.mrrev.2010.01.009
   PubMed Web of Science ®Google Scholar
• Cazzalini O, Perucca P, Mocchi R, Sommatis S, Prosperi E, Stivala LA. DDB2 association with PCNA is required for its degradation after UV-induced DNA damage. Cell Cycle 2014; 13 (2):240-8; PMID:24200966; http://dx.doi.org/10.4161/cc.26987
   PubMed Web of Science ®Google Scholar
• Chu G, Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 1988; 242(4878):564-7; PMID:3175673; http://dx.doi.org/10.1126/science.3175673
   PubMed Web of Science ®Google Scholar
• Datta A, Bagchi S, Nag A, Shiyanov P, Adami GR, Yoon T, Raychaudhuri P. The p48 subunit of the damaged-DNA binding protein DDB associates with the CBP/p300 family of histone acetyltransferase. Mutat Res 2001; 486(2):89-97; PMID:11425514; http://dx.doi.org/10.1016/S0921-8777(01)00082-9
   PubMed Web of Science ®Google Scholar
• Dutto I, Tillhon M, Cazzalini O, Stivala LA, Prosperi E. Biology of the cell cycle inhibitor p21(CDKN1A): molecular mechanisms and relevance in chemical toxicology. Arch Toxicol 2015; 89(2):155-78; PMID:25514883; http://dx.doi.org/10.1007/s00204-014-1430-4
   PubMed Web of Science ®Google Scholar
• Ennen M, Klotz R, Touche N, Pinel S, Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC, Ledrappier S, et al. DDB2: a novel regulator of NF-κB and breast tumor invasion. Cancer Res 2013; 73(16):5040-52; PMID:23774208; http://dx.doi.org/10.1158/0008-5472.CAN-12-3655
   PubMed Web of Science ®Google Scholar
• Han C, Zhao R, Liu X, Srivastava A, Gong L, Mao H, Qu M, Zhao W, Yu J, Wang QE. DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer. Mol Cancer Res 2014; 12(5):784-94; PMID:24574518; http://dx.doi.org/10.1158/1541-7786.MCR-13-0638
   PubMed Web of Science ®Google Scholar
• Hayes S, Shiyanov P, Chen X, Raychaudhuri P. DDB, a putative DNA repair protein, can function as a transcriptional partner of E2F1. Mol Cell Biol 1998; 18(1):240-9; PMID:9418871; http://dx.doi.org/10.1128/MCB.18.1.240
   PubMed Web of Science ®Google Scholar
• Huh J, Piwnica-Worms H. CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 2013; 33(2):213-26; PMID:23109433; http://dx.doi.org/10.1128/MCB.00847-12
   PubMed Web of Science ®Google Scholar
• Itoh T, Linn S, Ono T, Yamaizumi M. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them. J Invest Dermatol 2000; 114(5):1022-9; PMID:10771487; http://dx.doi.org/10.1046/j.1523-1747.2000.00952.x
   PubMed Web of Science ®Google Scholar
• Itoh T, Yamaizumi M. UVs syndrome: establishment and characterization of fibroblastic cell lines transformed with simian virus 40 DNA. J Invest Dermatol 2000; 114(1):101-6; PMID:10620123; http://dx.doi.org/10.1046/j.1523-1747.2000.00843.x
   PubMed Web of Science ®Google Scholar
• Kattan Z, Marchal S, Brunner E, Ramacci C, Leroux A, Merlin JL, Domenjoud L, Dauça M, Becuwe P. Damaged DNA binding protein 2 plays a role in breast cancer cell growth. PLoS One 2008; 3(4):e2002; PMID:18431487; http://dx.doi.org/10.1371/journal.pone.0002002
   PubMed Web of Science ®Google Scholar
• Kim Y, Starostina NG, Kipreos ET. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev 2008; 22(18):2507-19; PMID:18794348; http://dx.doi.org/10.1101/gad.1703708
   PubMed Web of Science ®Google Scholar
• Kreis NN, Sanhaji M, Rieger MA, Louwen F, Yuan J. p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene 2014; 33(50):5716-28; PMID:24317508; http://dx.doi.org/10.1038/onc.2013.518
   PubMed Web of Science ®Google Scholar
• Liu L, Lee S, Zhang J, Peters S B, Hannah J, Zhang Y, Yin Y, Koff A, Ma L, Zhou P. CUL4A Abrogation Augments DNA Damage Response and Protection Against Skin Carcinogenesis. Mol Cell 2009; 34(4):451-60; PMID:19481525; http://dx.doi.org/10.1016/j.molcel.2009.04.020
   PubMed Web of Science ®Google Scholar
• Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, Kundu TK, Chait BT, Roeder RG. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol 2001; 21(20):6782-95; PMID:11564863; http://dx.doi.org/10.1128/MCB.21.20.6782-6795.2001
   PubMed Web of Science ®Google Scholar
• Minig V, Kattan Z, van Beeumen J, Brunner E, Becuwe P. Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells. J Biol Chem 2009; 284(21):14165-76; PMID:19339246; http://dx.doi.org/10.1074/jbc.M808208200
   PubMed Web of Science ®Google Scholar
• Nichols AF, Itoh T, Graham JA, Liu W, Yamaizumi M, Linn S. Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation. J Biol Chem 2000; 275(28):21422-8; PMID:10777490; http://dx.doi.org/10.1074/jbc.M000960200
   PubMed Web of Science ®Google Scholar
• Nishitani H1, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem 2008; 283(43):29045-52; http://dx.doi.org/10.1074/jbc.M806045200
   Google Scholar
• Roy N, Bommi PV, Bhat UG, Bhattacharjee S, Elangovan I, Li J, Patra KC, Kopanja D, Blunier A, Benya R, Bagchi S, Raychaudhuri P. DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer. Cancer Res 2013; 73(12):3771-82; PMID:23610444; http://dx.doi.org/10.1158/0008-5472.CAN-12-4069
   PubMed Web of Science ®Google Scholar
• Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. DDB2, an essential mediator of premature senescence. Mol Cell Biol 2010; 30(11):2681-92; PMID:20351176; http://dx.doi.org/10.1128/MCB.01480-09
   PubMed Web of Science ®Google Scholar
• Stivala LA, Cazzalini O, Prosperi E. The cyclin-dependent kinase inhibitor p21CDKN1A as a target of anti-cancer drugs. Curr Cancer Drug Targets 2012; 12(2):85-96; PMID:22165965; http://dx.doi.org/10.2174/156800912799095126
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol 2008; 28(1):177-87; PMID:17967871; http://dx.doi.org/10.1128/MCB.00880-07
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Roy N, Bhattacharjee S, Kopanja D, Valli T, Bagchi S, Raychaudhuri P p21 cooperates with DDB2 protein in suppression of UV ray-induced skin malignancies. J Biol Chem 2012; 287 (5):3019-28; PMID:22167187; http://dx.doi.org/10.1074/jbc.M111.295816
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Roy N, Kopanja D, Bagchi S, Raychaudhuri P DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci U S A 2009; 106(26):10690-5; PMID:19541625; http://dx.doi.org/10.1073/pnas.0812254106
   PubMed Web of Science ®Google Scholar
• Tan T, Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 2002; 22(10):3247-54; PMID:11971958; http://dx.doi.org/10.1128/MCB.22.10.3247-3254.2002
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang X, Legerski RJ. Artemis interacts with the Cul4A-DDB1DDB2 ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27. Cell Cycle 2011; 10(23):4098-109; PMID:22134138; http://dx.doi.org/10.4161/cc.10.23.18227
   PubMed Web of Science ®Google Scholar
• Yeh JI, Levine AS, Du S, Chinte U, Ghodke H, Wang H, Shi H, Hsieh CL, Conway JF, Van Houten B, Rapić-Otrin V. Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatinized DNA repair. Proc Natl Acad Sci U S A 2012; 109(41):E2737-46; PMID:22822215; http://dx.doi.org/10.1073/pnas.1110067109
   PubMed Web of Science ®Google Scholar